f.chowdhury

TL2 · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 24 September 2025 · last posted 2d · groups: regional-apac

81 posts, newest first. Showing up to 150.

Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #100 · Practice › Dosing & titration · 26 Jul 2026 · 27 likes Confirming post #97 from a second method, which matters more than confirming it from a second person. There is no published evidence about slower escalation because…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #16 · Compounds › Tirzepatide · 23 Jul 2026 · 21 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…
Publication patterns in the BPC-157 literature, examined Replied, post #42 · Compounds › Repair & healing peptides · 22 Jul 2026 · 16 likes On post #38 — agreed on the reasoning, with one qualification. I have no financial interest in anything named in this thread and I want to say so before I comment on…
Common supplements people ask about, assessed one at a time Replied, post #59 · Practice › Interactions · 17 Jul 2026 · 32 likes Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist. That…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #32 · Compounds › Repair & healing peptides · 15 Jul 2026 · 2 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
Journal club: what we got wrong in an earlier session Replied, post #70 · Evidence › Journal club · 10 Jul 2026 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Where the group cannot agree, record the disagreement rather than resolving it by seniority.…
Tracking a shortage from primary sources rather than rumour Replied, post #85 · Access › Shortages · 5 Jul 2026 · 2 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated.
Journal club: LEADER as the historical anchor Replied, post #99 · Evidence › Journal club · 4 Jul 2026 · 5 likes Post #98 answers the question as asked. The question underneath it is different. The figures usually contain the finding and the text usually contains the…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #16 · Analytics › Mass spectrometry · 4 Jul 2026 · 27 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
How to ask a question when you cannot say why you are asking it Replied, post #30 · Start Here › How to Ask · 4 Jul 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
A structured critique template this community uses — a second dataset Replied, post #25 · Evidence › Study critique · 1 Jul 2026 · 7 likes A critique should end with what would change your mind. Without that it is a position rather than an argument. For what it is worth, the same held on the two occasions…
Alcohol: what is documented and what is folklore Replied, post #87 · Practice › Interactions · 1 Jul 2026 · 33 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…
Insurance and replacement policies, compared Replied, post #48 · Sourcing › Logistics · 28 Jun 2026 · 2 likes No notes. Posting so the count is not one.
Batch numbers that do not match the vial label — what changed since Replied, post #40 · Sourcing › Red flags · 17 Jun 2026 · 0 likes An observation about Batch numbers that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
Sample size intuition for a personal experiment — does this still hold? Replied, post #30 · Research Methods › Statistics · 6 Jun 2026 · 25 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction. Not the…
Pooling trials with different estimands Replied, post #2 · Evidence › Meta-analyses · 31 May 2026 · 0 likes The reason pooling trials with different estimands keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the…
Documenting a supplier's response to a discrepancy Replied, post #5 · Sourcing › Vendor reports · 29 May 2026 · 26 likes Right, and stated more narrowly than I would have dared to state it.
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #117 · Pharmacology › Pharmacokinetics · 24 Apr 2026 · 0 likes The thing about Washout that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Coming back to: Measurement error in a self-reported exposure Replied, post #14 · Evidence › Study critique · 24 Apr 2026 · 11 likes Second this, and I would have said it less carefully.
Follow-up: Sleep quality changes during weight loss Replied, post #5 · Wellbeing › Sleep · 15 Apr 2026 · 8 likes Consistency of timing does more for most people's sleep than any intervention discussed in this subcategory.
Fasting versus non-fasting and which tests care Replied, post #10 · Clinical › Bloodwork · 10 Apr 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
How to ask about something you suspect is a bad idea Replied, post #73 · Start Here › How to Ask · 5 Apr 2026 · 8 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #22 · Practice › Administration · 2 Apr 2026 · 15 likes Where I part company with post #20, and it is a narrow parting. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…
Citation sweep results: how many references did not say what was claimed Replied, post #70 · Meta › Wiki maintenance · 1 Apr 2026 · 1 like One caution on citation sweep results: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #76 · Clinical › Special populations · 17 Mar 2026 · 28 likes Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment.
Managing an unplanned gap in supply Replied, post #60 · Access › Shortages · 14 Mar 2026 · 5 likes That matches what I have seen, for whatever a single anecdote is worth.
Angle of injection and whether 90 degrees is always right Replied, post #80 · Practice › Administration · 10 Jan 2026 · 23 likes Confirming post #77 from a second method, which matters more than confirming it from a second person. The single most common technique error described here is drawing…
Oral semaglutide bioavailability and its variability between people Replied, post #26 · Compounds › Oral incretins · 7 Jan 2026 · 19 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #63 · Clinical › Special populations · 29 Dec 2025 · 19 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating. Worth saying I have only…
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 26 Dec 2025 · 7 likes Native amylin has awkward physical properties — it aggregates readily, which is why a stable analogue is a pharmaceutical achievement rather than a formulation detail.
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #46 · Compounds › Semaglutide · 19 Dec 2025 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #13 · Access › International · 15 Dec 2025 · 0 likes Worth separating two things that post #9 runs together. The most useful thing anyone can add to a thin regional thread is what the official source says and where it is,…
A history of disordered eating: proceeding carefully Replied, post #20 · Wellbeing › Mental health · 5 Dec 2025 · 16 likes Post #16 describes the usual case. This is about the unusual one. Motivation and expectation: starting with clear motivation and realistic expectations about what will…
Tracking a preprint to publication: a worked example Replied, post #47 · Evidence › Preprints · 4 Dec 2025 · 30 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #14 · Safety › Contraindications · 29 Nov 2025 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #22 · Data & Tools › Calculators · 29 Nov 2025 · 0 likes What I want from this Feature request thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Thyroid function tests during substantial weight change Replied, post #126 · Clinical › Bloodwork · 8 Nov 2025 · 6 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. I keep a…
Thyroid function tests during substantial weight change Replied, post #95 · Clinical › Bloodwork · 14 Oct 2025 · 12 likes Sensible. I would want the same detail before I acted on it either.
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #32 · Analytics › Method validation · 14 Oct 2025 · 6 likes The arithmetic in post #29 is right; the assumption feeding it is the part to check. Accuracy for a purity assay is usually demonstrated by spike recovery across a…
Publishing an inconvenient result: a case study — the long version Replied, post #9 · Sourcing › Independent verification · 13 Oct 2025 · 6 likes Post #5 put the caveat in the right place and I want to underline it. Practical note on Publishing an inconvenient result: write down what you expect before you look.…
Managing an unplanned gap in supply — what changed since Replied, post #85 · Access › Shortages · 11 Oct 2025 · 0 likes Nobody has said the unglamorous part of Managing an unplanned gap yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #5 · Practice › Side effects · 2 Oct 2025 · 27 likes Post #3 put the caveat in the right place and I want to underline it. A symptom that starts weeks after a dose has been stable is a different observation from one that…
A parcel that arrived warm: a decision process, not a verdict Replied, post #60 · Practice › Storage & stability · 29 Sep 2025 · 11 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
What a purity-only report leaves out Replied, post #25 · Sourcing › Independent verification · 25 Sep 2025 · 1 like Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Power cut for eleven hours: how I assessed it afterwards Replied, post #59 · Practice › Storage & stability · 16 Sep 2025 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on power cut for eleven hours, because it is the sort of subject…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #21 · Analytics › Method validation · 12 Sep 2025 · 6 likes Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it. Someone will…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #78 · Evidence › Journal club · 5 Sep 2025 · 7 likes That is clearer than the version I had in my head. Thank you.
Risk-of-bias tools and the judgement they conceal Replied, post #8 · Evidence › Meta-analyses · 18 Jul 2025 · 1 like What would change my mind on risk-of-bias tools is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…
Asking about a compound your prescriber has not heard of Replied, post #70 · Clinical › Prescriber conversations · 19 Jun 2025 · 22 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Two sources, same conclusion,…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #48 · Nutrition & Training › Protein & intake · 9 Jun 2025 · 23 likes The arithmetic in post #47 is right; the assumption feeding it is the part to check. Fibre: adequate fibre intake supports fullness and gut motility, both of which…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #24 · Evidence › Journal club · 2 Jun 2025 · 9 likes I would call the community position on CagriSema phase 2 combination paper likely rather than established, and I would be comfortable defending that hedge.
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #10 · Compounds › Secretagogues & GH axis · 28 May 2025 · 0 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #12 · Pharmacology › Pharmacokinetics · 23 May 2025 · 21 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Clearance pathways, because it is the sort of subject where it…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #74 · Compounds › Tirzepatide · 1 May 2025 · 17 likes Worth separating tirzepatide in type 2 diabetes as a question about the compound from tirzepatide in type 2 diabetes as a question about the documentation. They get…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #5 · marked as the solution · Analytics › Method validation · 1 May 2025 · 6 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. I have…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #141 · Sourcing › Regulatory · 30 Apr 2025 · 13 likes If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. I would…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #99 · Evidence › Journal club · 21 Apr 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #36 · Clinical › Comorbidities · 18 Mar 2025 · 0 likes Narrowing post #33, because the general version has more than one answer. What I want from this obstructive sleep apnoea thread is the list of things that would need to…
Charge states for a 4 kDa peptide, worked through Replied, post #123 · Analytics › Mass spectrometry · 16 Mar 2025 · 0 likes I read post #121 twice before replying, because I had assumed the opposite. Positional isomers and epimers are mass-identical. Any argument that a mass result rules…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #25 · Sourcing › Vendor reports · 15 Mar 2025 · 2 likes On post #24 — agreed on the reasoning, with one qualification. Date the submission as well as the result. Turnaround is part of what people want to know and it…
Validating a method you did not develop — does this still hold? Replied, post #47 · Analytics › Method validation · 26 Feb 2025 · 2 likes Thank you — that answers what I came here to find out.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #64 · Compounds › Semaglutide · 15 Feb 2025 · 23 likes No disagreement from me. Posting only so the question does not look ignored.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #26 · Practice › Reconstitution · 4 Feb 2025 · 2 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…
Talking to a therapist about this specifically — does this still hold? Replied, post #12 · Wellbeing › Mental health · 2 Feb 2025 · 1 like Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #28 · Evidence › Journal club · 25 Jan 2025 · 14 likes Bringing the previous paper on the same question makes the session much better and doubles the preparation. Worth doing every third session rather than every one. That…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #73 · Evidence › Journal club · 27 Dec 2024 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #96 · Compounds › Tirzepatide · 18 Dec 2024 · 0 likes Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about rather than worth alarm — and it is one of the…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 14 Dec 2024 · 21 likes Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be used together rather than instead of each other. I…
Body image changing more slowly than the body Replied, post #3 · Wellbeing › Mental health · 9 Dec 2024 · 0 likes Body image is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
What would change my mind about repair peptides: a specific answer — one year on Replied, post #10 · Compounds › Repair & healing peptides · 3 Dec 2024 · 6 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.…
A promotion I argued against, and why I lost Replied, post #16 · Documentation › Doc review · 29 Nov 2024 · 33 likes Filing a mild objection to the consensus on promotion. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
When a red flag was a misunderstanding, and the retraction Replied, post #32 · Sourcing › Red flags · 11 Oct 2024 · 0 likes Adding the measurement that post #31 says would settle it. Worth stating the null on red flag before we explain it: the observation may be nothing. That possibility…
Blind submission and why it changes minds Replied, post #68 · Sourcing › Independent verification · 22 Sep 2024 · 6 likes Post #67 answers the question as asked. The question underneath it is different. Blind submission is one of those subjects where the general answer and the answer for a…
Correlation in a self-tracked dataset: what it can support Replied, post #160 · Research Methods › Statistics · 26 Aug 2024 · 12 likes Correlation is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
High-resolution MS on aggregates and what it can see — one year on Replied, post #47 · Analytics › Mass spectrometry · 19 Aug 2024 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed High-resolution, as opposed to read about it? The thread is long and I cannot tell.
Circumference measurements as a poor man's composition estimate Replied, post #34 · Outcomes › Body composition · 1 Aug 2024 · 23 likes Picking up post #31: that is the part I would want checked first. Percentage body fat is a ratio, so it changes when either component changes. A rising percentage…
Guidelines revision: what changed and why Replied, post #83 · Meta › Announcements · 27 Jul 2024 · 3 likes Two people in this thread mean different things by guidelines revision and are disagreeing about the definition while believing they are disagreeing about the facts.…
How to ask for a dose change without antagonising anyone Replied, post #7 · Clinical › Prescriber conversations · 21 Jul 2024 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
Cold packs, phase-change material, and what survives ten days Replied, post #109 · Sourcing › Logistics · 16 Jul 2024 · 10 likes Building on post #106 rather than restating it. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at…
How this community labels and discusses unrefereed work Replied, post #69 · Evidence › Preprints · 8 Jul 2024 · 0 likes Post #66 answers the question as asked. The question underneath it is different. A preprint with the data and code attached is frequently more checkable than a…
The mass-error checker and its intended scope Replied, post #12 · Data & Tools › Calculators · 25 May 2024 · 2 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with.